BioSpace News Archive

Pharm Country

Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments

Bristol Myers Squibb (NYSE: BMY) today announced meaningful progress toward its global inclusion & diversity goals and health equity commitments, meeting and exceeding some goals ahead of schedule.

March 15, 2023
·
5 min read
Exscientia to Present Data Highlighting Pipeline and Precision Medicine Platform at AACR

Exscientia plc (Nasdaq: EXAI) today announced that four abstracts have been accepted for poster presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, being held April 14-19, 2023.

March 15, 2023
·
8 min read
Business

Silence Therapeutics Reports Fourth Quarter and Full Year 2022 Results

Silence Therapeutics plc today reported its financial results for the fourth quarter and full year ended December 31, 2022 and reviewed recent business highlights.

March 15, 2023
·
9 min read
Drug Development

Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single Ascending Dose Safety/Tolerability/PK/PD Trial of EVX-301

Evecxia Therapeutics, Inc. announced favorable safety, tolerability, pharmacokinetics, and pharmacodynamics data from a double-blind, placebo-controlled Phase 1 single ascending dose study of EVX-301 in healthy volunteers pre-treated with escitalopram for three weeks.

March 15, 2023
·
4 min read
Business

Kamada Issues 2023 CEO Letter to Shareholders

Kamada Ltd. today issued a Letter to Shareholders from Amir London, Chief Executive Officer.

March 15, 2023
·
13 min read
BioForest

LumiThera Announces Sustained Vision Improvement for 24 months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data

LumiThera Inc. today announced the 24-month data from its LIGHTSITE III, multi-center clinical trial which demonstrated sustained vision improvement in dry Age-Related Macular Degeneration (AMD) subjects treated with the Valeda ® Light Delivery System.

March 15, 2023
·
5 min read
Business

BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights

BrainsWay Ltd. today reported fourth quarter and full-year 2022 financial results and provided an operational update.

March 15, 2023
·
11 min read
BioMidwest

Quipt Home Medical to Participate at the Sidoti Small-Cap Virtual Investor Conference on March 22-23, 2023 Webcasted Presentation To Be Held Wednesday, March 22, 2023

Quipt Home Medical Corp. today announced that members of its management team will host a webcasted presentation and participate in 1x1 meetings with institutional investors at the upcoming Sidoti March Small-Cap Virtual Conference on March 22-23, 2023.

March 15, 2023
·
1 min read
Business

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

NEXGEL, Inc. today announced it will report its financial results for the fourth quarter and full year periods ended December 31, 2022, after the market closes on March 27, 2023.

March 15, 2023
·
1 min read
Pharm Country

Context Therapeutics Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2023

Context Therapeutics Inc. today announced that an abstract regarding Context’s preclinical candidate, CTIM-76, a Claudin 6 x CD3 bispecific antibody, has been selected for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023.

March 15, 2023
·
4 min read